ClinicalTrials.Veeva

Menu

Central Venous Catheter Placement With Thoracic Ultrasound and Intracavity ECG Positioning (CVC-TIP)

Y

York Teaching Hospitals NHS Foundation Trust

Status

Not yet enrolling

Conditions

Point of Care Ultrasound (POCUS)
Intracavitary Electrocardiogram Guiding
Feasibility Studies
Central Venous Catheter

Treatments

Device: Intracavity ECG
Diagnostic Test: Thoracic point of care ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT07291869
360875 (Other Identifier)

Details and patient eligibility

About

The goal of this interventional study is to assess the feasibility of two bedside techniques for confirming central venous catheter (CVC) placement and detecting complications:

  • Intracavity ECG monitoring to confirm internal jugular vein CVC tip position.
  • Thoracic point-of-care ultrasound (POCUS) to rule out pneumothorax following CVC insertion.

Participants who require an internal jugular CVC as part of their routine care and meet all inclusion and no exclusion criteria will be randomised to receive either:

  • Standard care, or
  • The intervention, consisting of intracavity ECG guidance and thoracic POCUS. The CVC will be inserted either on the left or right side of the neck.

All participants will undergo a post-procedure chest X-ray regardless of study arm, to allow comparison of the intervention methods with standard care.

Full description

Central venous catheters (CVCs) are commonly inserted in critically ill patients to enable the administration of medications, fluids, and monitoring. Following insertion, it is standard practice to perform a chest X-ray (CXR) to confirm correct catheter tip position and exclude complications such as pneumothorax. However, reliance on post-procedure radiography can delay verification of line position, increase patient radiation exposure, and contribute to workflow inefficiency.

Alternative bedside techniques have been proposed to improve the speed and safety of CVC verification. Intracavity electrocardiography (IC-ECG) uses the patient's cardiac electrical activity to confirm the catheter tip's location in real time. When the catheter tip approaches the cavoatrial junction, a characteristic increase in P-wave amplitude is observed, allowing for accurate placement without the need for immediate imaging. Thoracic point-of-care ultrasound (POCUS) has been shown to be an effective method for detecting pneumothorax following CVC insertion.

This single-centre, prospective, randomised feasibility study will evaluate the combined use of intracavity ECG for tip confirmation and thoracic POCUS for pneumothorax exclusion in patients requiring internal jugular CVC insertion. Eligible participants will be randomised to receive either:

  • Standard care (ultrasound-guided insertion with post-procedure CXR), or
  • The intervention, consisting of ultrasound-guided insertion supplemented with intracavity ECG confirmation and thoracic POCUS assessment, followed by a post-procedure CXR for comparison.

The primary objective is to determine the feasibility of implementing these combined techniques within a critical care environment, including assessment of recruitment, protocol adherence, and completeness of data acquisition. Secondary outcomes include the accuracy of IC-ECG and POCUS compared to CXR for tip position and pneumothorax detection, and the time required to confirm line placement.

The findings will inform the design of a future multi-centre study to assess diagnostic accuracy, cost-effectiveness, and potential to replace routine post-procedure chest X-ray in appropriate clinical settings.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (aged ≥ 18 years)
  • Admitted, or planned for admission, to critical care
  • Requiring central venous catheter insertion as a part of their usual care
  • Suitable for both right or left internal jugular vein insertion

Exclusion criteria

  • Previously randomised into CVC-TIP
  • Atrial fibrillation on 12-lead ECG
  • Cardiovascular instability, defined as
  • Noradrenaline dose > 0.5mcg/kg/min
  • Rapidly escalating doses of vasopressors / inotropes
  • Difficulty in obtaining thoracic ultrasound images due to either
  • Weight > 120kg
  • Existing pneumothorax (either side)
  • Subcutaneous emphysema
  • Wounds / dressing over anterior chest wall
  • Existing pacemaker
  • Non-English speaking participants
  • Death perceived as imminent
  • Any other reason as determined by treating clinician

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

75 participants in 3 patient groups

LEFT internal jugular vein CVC with IC-ECG and thoracic POCUS
Active Comparator group
Description:
LEFT internal jugular vein CVC with IC-ECG and thoracic POCUS. Post procedure chest x-ray.
Treatment:
Diagnostic Test: Thoracic point of care ultrasound
Device: Intracavity ECG
RIGHT internal jugular vein CVC with IC-ECG and thoracic POCUS
Active Comparator group
Description:
RIGHT internal jugular vein CVC with IC-ECG and thoracic POCUS. Post procedure chest x-ray.
Treatment:
Diagnostic Test: Thoracic point of care ultrasound
Device: Intracavity ECG
Standard care
No Intervention group
Description:
Left or right internal jugular vein CVC. Post procedure CXR.

Trial contacts and locations

1

Loading...

Central trial contact

Andrew Chamberlain, MBChB; Joseph Carter, MBChB

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems